Sucampo and Takeda announced that the FDA has approved the supplemental New Drug Application (sNDA) for Amitiza (lubiprostone) for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain.
Amitiza Approved for Opioid-Induced Constipation
